Explore the latest in neurology, including recent guidelines and advances in management of stroke, dementia, demyelinating disease, and more.
This cohort study examines the bidirectional associations between emerging adolescents’ perceptions of parental digital interruptions (technoference) and their anxiety, depression, attention difficulties, and hyperactivity symptoms.
This randomized clinical trial evaluates the efficacy of suvorexant in reducing delirium in older adults at high risk for delirium after hospitalization.
This cohort study uses latent growth curve modeling to analyze associations of personality, social factors, brain functioning, and family history with alcohol misuse over time among adolescents in Europe.
This Medical News article is an interview about the latest findings presented at the recent Alzheimer’s Association International Conference.
This nonrandomized controlled trial investigates central nervous system (CNS) activity with lazertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
This cohort study assesses whether antithrombin III deficiency is associated with thrombohemorrhagic complications among patients with trauma.
This cross-sectional study of middle-aged US adults examines the association of traumatic brain injury (TBI) with neuroimaging and clinical outcomes.
This study compares likelihood of withdrawal of life-supporting treatment and mortality in patients with complete cervical spinal cord injury with different types of insurance.
This cross-sectional study investigates whether an artificial intelligence (AI) large language model can accurately and reliably analyze clinical narratives and identify helmet use status of patients injured in accidents involving e-bikes, bicycles, hoverboards, and powered scooters.
This narrative review discusses the results of 6 recently published trials on the efficacy and safety of endovascular thrombectomy as treatment for patients with ischemic stroke, anterior-circulation large vessel occlusions, and large areas of ischemic change and highlights areas of persistent uncertainty in the use of this treatment.
This case report describes a 67-year-old woman who had received adoptive immunotherapy with chimeric antigen receptor T cells for multiple myeloma and was experiencing parkinsonism-like symptoms.
This secondary analysis of the Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke (ARCADIA) randomized clinical trial compares apixaban vs aspirin for the prevention of adverse clinical outcomes in patients with history of cancer and cryptogenic stroke.
This cohort study examines the risk of dementia in individuals with cardiometabolic diseases following anti-inflammatory vs proinflammatory diets.
This cohort study evaluates whether age is associated with functional outcomes and mortality among patients with acute ischemic strokes with large infarct who undergo endovascular thrombectomy.
This cross-sectional study examines the use of community-based efforts to increase the level of screening and enrollment of Black and Latinx individuals into Alzheimer disease studies through the Alzheimer’s Disease Neuroimaging Initiative-3 (ADNI3).
This cohort study compares the validity of patient-reported outcome measures with neurophysiological and sensory functional measures for the assessment of chemotherapy-induced peripheral neuropathy among adults in Australia.
This cohort study investigates the association of traumatic brain injury and seizures with the risk of cognitive impairment among cognitively normal older adults from diverse racial and ethnic groups and the role of medications in moderating the association.
This systematic review and meta-analysis quantifies differences in plasma concentrations for antiseizure drugs associated with variants of genes encoding drug metabolizing enzymes, particularly CYP2C9 and CYP2C19.
Customize your JAMA Network experience by selecting one or more topics from the list below.